Description
FOXO4-DRI is a synthetic peptide designed to disrupt the interaction between FOXO4 and p53 in senescent cells, studied in senolytic and cellular-aging research for its selective effect on senescent-cell viability.
| Format | Lyophilized powder, 10mg × 10 vials |
| Purity | ≥98% (HPLC verified) |
| Storage | -20°C lyophilized, protected from light; 2-8°C after reconstitution |
FOXO4-DRI was designed to break one specific interaction — FOXO4 holding onto p53 inside senescent cells. Senolytic researchers use it because that interaction seems to be what keeps zombie cells alive in the first place.






Reviews
There are no reviews yet.